Famrisc, a RCT comparing mammography with MRI in screening for familial risk.

Autor: Geuzinge, Amarens, Saadatmand, Sepideh, Rutgers, Emiel, Obdeijn, Inge-Marie, de Roy van Zuidewijn, Diderick, Tollenaar, Rob, Margrethe, Schlooz-Vries, Riet, Martijne van 't, Hooning, Maartje, Wesseling, Jelle, Mares-Engelberts, Ingeborg, Ausems, Margreet, Keymeulen, Kristine, Zonderland, Harmien, Heijnsdijk, Eveline, Luiten, Ernest, Verhoef, Cees, Oosterwijk, Jan, de Koning, Harry, Tilanus-Linthorst, Madeleine
Předmět:
Zdroj: European Journal of Surgical Oncology; Feb2020, Vol. 46 Issue 2, pe19-e19, 1p
Abstrakt: B Background: b Screening guidelines advise women at familial risk of breast cancer without a known causative gene mutation MRI-screening in the USA but mammography in Europe. In incident cancers, tumour stage was better in the MRI-group (p=0-035), with lower numbers of node positive and >=T2 tumours, and specificity improved in both arms (MRI- vs. [Extracted from the article]
Databáze: Supplemental Index